| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2021 | Feb 2020 | Mar 2019 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 33.15B | 32.81B | 32.70B | 29.89B | 29.05B | 28.99B |
| Gross Profit | 2.07B | 2.22B | 2.34B | 2.21B | 2.04B | 2.19B |
| EBITDA | 2.21B | 2.19B | 1.99B | 2.40B | 1.34B | 1.90B |
| Net Income | 355.61M | 242.00M | 137.00M | 677.00M | -208.00M | 152.00M |
Balance Sheet | ||||||
| Total Assets | 19.51B | 24.65B | 25.06B | 27.15B | 25.47B | 28.17B |
| Cash, Cash Equivalents and Short-Term Investments | 1.47B | 3.39B | 2.00B | 1.02B | 1.67B | 1.08B |
| Total Debt | 6.54B | 6.61B | 6.55B | 7.38B | 6.94B | 7.42B |
| Total Liabilities | 13.11B | 18.00B | 18.19B | 18.73B | 18.77B | 20.64B |
| Stockholders Equity | 6.40B | 6.65B | 6.87B | 8.42B | 6.70B | 7.53B |
Cash Flow | ||||||
| Free Cash Flow | -1.17B | 505.00M | 548.00M | 202.00M | 1.50B | 1.05B |
| Operating Cash Flow | -492.00M | 1.36B | 1.97B | 896.00M | 2.10B | 1.69B |
| Investing Cash Flow | -220.00M | -787.00M | -1.01B | -651.00M | -575.00M | -571.00M |
| Financing Cash Flow | -1.13B | -1.12B | -282.00M | -1.02B | -1.31B | -1.07B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | $10.26B | 23.26 | 6.43% | 7.46% | 4.42% | 165.05% | |
67 Neutral | $1.65B | 17.86 | 7.22% | 2.06% | 3.11% | 6.54% | |
65 Neutral | $7.00B | 13.97 | 38.43% | ― | 16.60% | 49.76% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
61 Neutral | $9.10B | 11.53 | 29.65% | 3.49% | 2.08% | -1.63% | |
59 Neutral | $43.70B | 62.50 | 7.75% | 2.15% | -1.77% | -70.83% | |
52 Neutral | $907.77M | -194.33 | -0.37% | ― | 7.22% | -108.99% |